CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) has completed the installation of a 295 kW solar photovoltaic (PV) system at the company’s Cheshire, Conn., corporate headquarters and research facility. State officials and other guests joined Alexion employees at yesterday’s ceremony to “throw the switch” on the new system.
